Novartis AG (TSX:NVS)

Market Cap	353.72B
Revenue (ttm)	78.52B
Net Income (ttm)	20.05B
Shares Out	n/a
EPS (ttm)	10.17
PE Ratio	17.64
Forward PE	15.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103
Average Volume	1,359
Open	24.68
Previous Close	n/a
Day's Range	24.68 - 24.68
52-Week Range	20.11 - 25.84
Beta	n/a
RSI	53.64
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD